An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
Adv Radiat Oncol
; 8(1): 101083, 2023.
Article
in En
| MEDLINE
| ID: mdl-36483060
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Adv Radiat Oncol
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos